A unique pharmaceutical company

Orphan Europe, part of the Recordati group, is a unique pharmaceutical company focusing on the research and development of orphan medicinal products. Since 1990 we have used big thinking and extensive know-how on behalf of people affected by rare diseases. Patients and their families are central to our planning, our thinking and our actions. Recordati orphan drugs is present in the USA through its company Recordati Rare Diseases.

News and events

Meet Orphan Europe and physicians during the 11th Middle East Metabolic Group (MEMG) in Marrakech (Morroco), from the 22th to the 25th october

Orphan Europe has organised an interactive Satellite Symposium entitled Age is no barrier: time to consider late-onset UCDs at the SSIEM annual meeting. It was held in Innsbruck, Austria on Thursday 4 September 2014. The Symposium was attended by more than 170 participants and was very well received based on the physicians’ feedback.

A personal “Thank you” for the participants by Dr. Robin Lachmann, the Chairman of the Symposium can be found here